HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

Executive Summary

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.

You may also be interested in...



French OTC Industry Warns Over-Regulation Is Threatening Its Future

Plans to move ibuprofen, aspirin and paracetamol OTCs behind the counter in French pharmacies will harm the country's self-medication industry, which is already lagging behind its European neighbors, warns local association Afipa.

France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth

France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.

France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth

France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.

Topics

Related Companies

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel